University Of Washington School Of Medicine

Recruitment is underway for a small study focused on the ability of psilocybin to reduce anxiety among individuals with metastatic cancer.

The availability of highly effective targeted agents has changed the treatment landscape for chronic lymphocytic leukemia, but key questions about optimal strategies remain, according to a review published in JAMA.

An analysis of individuals in the United States with public insurance showed that those with sickle cell disease died more than 20 years earlier than the average person.

Community oncologists who received peer coaching from cancer genetics experts more frequently ordered genetic testing for their patients, according to study results.

Dexrazoxane appeared to have a cardioprotective effect almost 2 decades after exposure to anthracyclines among a cohort of young adults who survived childhood cancer, according to study results published in Journal of Clinical Oncology.

SEATTLE — A monthly dapivirine vaginal ring, used by women as HIV prophylaxis, is safe for breastfeeding babies, according to results of a phase 3b trial presented at the Conference on Retroviruses and Opportunistic Infections 2023.

NEW ORLEANS — Most hematopoietic stem cell transplant recipients received at least one dose of COVID-19 vaccine, according to single-institution study results presented at ASH Annual Meeting and Exposition.

Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

According to published results, use of a 0.05% chlorhexidine gluconate solution may serve as a chemical adjuvant to intralesional curettage for patients with chondrosarcomas and giant cell tumors.

An experimental plasmid DNA vaccine produced a strong immune response to the HER2 protein among women with advanced HER2-positive breast cancer, according to results of a single-arm, phase 1 study published in JAMA Oncology.